Analytical innovations top $10M in licensing income for PNNL, Battelle A suite of analytical innovations used to detect and measure suprisingly low degrees of compounds and elements for environmental, national security and wellness applications has topped $10 million in licensing income for Pacific Northwest National Laboratory and its own operator Battelle. Most of the money has been reinvested in brand-new research programs directly, demonstration projects, laboratory devices and staff at the Division of Energy national laboratory in Richland, or reinvested by Battelle in research-related activities consistent with its non-profit mission.

?powerful vasodilator

An update about contraception. Part 2: bands, implants and injections Long-acting reversible hormonal contraceptives are less prone to issues with compliance than the more commonly used combined pill and have great potential to reduce unplanned pregnancies. It is necessary to include a debate of their use in routine contraceptive motivate and counselling uptake, particularly in females who are at risky of unplanned pregnancies. Long-performing reversible contraceptives are underused in Australia. They are less prone to issues with compliance compared to the additionally used combined pill and also have great potential to reduce unplanned pregnancies.